Todd Schwarzinger is a managing director in the Life Sciences Group at Hercules Technology Growth Capital, the largest non-bank lender to venture capital-backed companies at all stages of development in the technology, energy technology, and life science sectors, where he focuses on the firm’s investment activities in the live sciences sector.
Todd has more than 15 years of investment banking and consulting experience with health care and life sciences companies. Prior to joining Hercules in 2015, Todd was an Executive Director in the health care investment banking division at Morgan Stanley, where he advised a broad range of medical device and biopharmaceutical clients on mergers and acquisitions, initial public offerings, and the equity and debt capital markets.
In his nearly nine year career at Morgan Stanley across both London and New York, he was responsible for life sciences M&A transactions totaling over 5B USD and raised over 3B USD in capital markets transactions spanning North America, Europe, and Asia. Prior to Morgan Stanley, Todd was a consultant for five years with Accenture in the health care sector, focused on supply chain management. Todd received his MBA from The Fuqua School of Business at Duke University and graduated with a BS in Finance from Miami University.